Shakher Ramdave

3.2k total citations
16 papers, 413 citations indexed

About

Shakher Ramdave is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, Shakher Ramdave has authored 16 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Neurology. Recurrent topics in Shakher Ramdave's work include Prostate Cancer Diagnosis and Treatment (5 papers), Prostate Cancer Treatment and Research (5 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Shakher Ramdave is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (5 papers), Prostate Cancer Treatment and Research (5 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Shakher Ramdave collaborates with scholars based in Australia, United States and Canada. Shakher Ramdave's co-authors include Damien Bolton, Rodney J. Hicks, Ian D. Davis, Duncan MacGregor, Salvatore U. Berlangieri, Andrew M. Scott, Grace Kong, Eddie Lau, Richard O’Sullivan and Arveen Kalapara and has published in prestigious journals such as The Journal of Urology, Anesthesia & Analgesia and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Shakher Ramdave

16 papers receiving 405 citations

Peers

Countries citing papers authored by Shakher Ramdave

Since Specialization

Citations

This map shows the geographic impact of Shakher Ramdave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shakher Ramdave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shakher Ramdave more than expected).

Fields of papers citing papers by Shakher Ramdave

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shakher Ramdave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shakher Ramdave. The network helps show where Shakher Ramdave may publish in the future.

Co-authorship network of co-authors of Shakher Ramdave

This figure shows the co-authorship network connecting the top 25 collaborators of Shakher Ramdave. A scholar is included among the top collaborators of Shakher Ramdave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shakher Ramdave. Shakher Ramdave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Can ⁶⁸ Ga‐PSMA positron emission tomography and multiparametric MRI guide treatment for biochemical recurrence after radical prostatectomy? 2023 ·British Journal of Urology ·(unknown), (unknown), (unknown), Richard O’Sullivan, (unknown), Andrew M. Ryan, Shakher Ramdave, (unknown), Patrick Bowden, Mario Guerrieri, Weranja Ranasinghe, Mark Frydenberg	3
2	Neurolymphomatosis: an uncommon manifestation of lymphoma – detection and therapeutic monitoring through 18F-fluorodeoxyglucose positron-emission tomography and computed tomography imaging 2022 ·BMJ Case Reports ·(unknown), (unknown), Mithun Nambiar, Shakher Ramdave	3
3	Combined Utility of 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging in Predicting Prostate Biopsy Pathology 2021 ·European Urology Oncology ·Arveen Kalapara, (unknown), Shakher Ramdave, Richard O’Sullivan, Anthony J. Ryan, Badrinath R. Konety, Jeremy Grummet, Mark Frydenberg	19
4	⁶⁸Ga‐prostate‐specific membrane antigen (PSMA) PET/CT as a clinical decision‐making tool in biochemically recurrent prostate cancer 2021 ·Asia-Pacific Journal of Clinical Oncology ·(unknown), Marcus Foo, Chun Loo Gan, John Kourambas, (unknown), (unknown), Sree Appu, Scott Williams, A Coleman, Eva Segelov, (unknown), (unknown), Shakher Ramdave, Edmond M. Kwan, Arun Azad	1
5	⁶⁸ Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography Maximum Standardized Uptake Value as a Predictor of Gleason Pattern 4 and Pathological Upgrading in Intermediate-Risk Prostate Cancer 2021 ·The Journal of Urology ·(unknown), Arveen Kalapara, (unknown), Sidney M. Levy, (unknown), Andrew M. Ryan, Shakher Ramdave, Richard O’Sullivan, Daniel Moon, Jeremy Grummet, Mark Frydenberg	15
6	Detection and localisation of primary prostate cancer using ⁶⁸ gallium prostate‐specific membrane antigen positron emission tomography/computed tomography compared with multiparametric magnetic resonance imaging and radical prostatectomy specimen pathology 2019 ·British Journal of Urology ·Arveen Kalapara, Tatenda Nzenza, (unknown), (unknown), Shakher Ramdave, Richard O’Sullivan, Anthony J. Ryan, Martin Cherk, Michael S. Hofman, Badrinath R. Konety, Nathan Lawrentschuk, Damien Bolton, Declan G. Murphy, Jeremy Grummet, Mark Frydenberg	73
7	Utility of SUVmax on 18 F-FDG PET in detecting cervical nodal metastases 2016 ·Cancer Imaging ·(unknown), Shakher Ramdave, Paul Beech, Baki Billah, Md Nazmul Karim, Julian A. Smith, Adnan Safdar, Elizabeth Sigston	20
8	Neuraxial Anesthesia Reduces Lymphatic Flow: Proof-of-Concept in First In-Human Study 2016 ·Anesthesia & Analgesia ·Jonathan G. Hiller, Hilmy Ismail, Michael S. Hofman, Kailash Narayan, Shakher Ramdave, Bernhard Riedel	6
9	Intravascular Small Cell Neuroendocrine Tumor in the Neck 2014 ·Clinical Nuclear Medicine ·(unknown), (unknown), (unknown), Shakher Ramdave	1
10	Dynamic four-dimensional computed tomography for preoperative assessment of lung cancer invasion into adjacent structures† 2014 ·European Journal of Cardio-Thoracic Surgery ·Cliff K. Choong, (unknown), Xun Li, Peter Briggs, Shakher Ramdave, Marcus Crossett, John M. Troupis	15
11	177Lu-octreotate, alone or with radiosensitising chemotherapy, is safe in neuroendocrine tumour patients previously treated with high-activity 111In-octreotide 2010 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Grace Kong, Michael Michael, (unknown), Shakher Ramdave, Rodney J. Hicks	49
12	High-Administered Activity In-111 Octreotide Therapy with Concomitant Radiosensitizing 5FU Chemotherapy for Treatment of Neuroendocrine Tumors: Preliminary Experience 2009 ·Cancer Biotherapy and Radiopharmaceuticals ·Grace Kong, (unknown), Shakher Ramdave, Eddie Lau, Danny Rischin, Rodney J. Hicks	41
13	Atypical Brown Fat Distribution in Young Males Demonstrated on PET/CT 2007 ·Clinical Nuclear Medicine ·James R. Clarke, (unknown), Eddie Lau, Shakher Ramdave, Rodney J. Hicks	18
14	Clinical experience with the first combined positron emission tomography/computed tomography scanner in Australia 2005 ·The Medical Journal of Australia ·Winnie Lau, David Binns, Robert E. Ware, Shakher Ramdave, Alexander Pitman, Rodney J. Hicks	14
15	CLINICAL ROLE OF F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR DETECTION AND MANAGEMENT OF RENAL CELL CARCINOMA 2001 ·The Journal of Urology ·Shakher Ramdave, (unknown), Salvatore U. Berlangieri, Damien Bolton, Ian D. Davis, (unknown), Duncan MacGregor, Andrew M. Scott	121
16	CLINICAL ROLE OF F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR DETECTION AND MANAGEMENT OF RENAL CELL CARCINOMA 2001 ·The Journal of Urology ·Shakher Ramdave, (unknown), Salvatore U. Berlangieri, Damien Bolton, Ian D. Davis, (unknown), Duncan MacGregor, Andrew M. Scott	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact